Stool microbiota characterization in patients with diarrhea-predominant irritable bowel syndrome (IBS-D) receiving repeat Rifaximin

被引:0
|
作者
Pimentel, M. [1 ]
Fodor, A. A. [2 ]
Golden, P. L. [3 ]
Bortey, E. [3 ]
Forbes, W. P. [3 ]
机构
[1] Cedars Sinai Med Ctr, Los Angeles, CA 90048 USA
[2] Univ North Carolina Charlotte, Charlotte, NC USA
[3] Salix, Bridgewater, NJ USA
来源
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
343
引用
收藏
页码:100 / 100
页数:1
相关论文
共 50 条
  • [1] Responders Analysis in Patients With Diarrhea-Predominant Irritable Bowel Syndrome IBS-D) Treated With Rifaximin
    Lembo, Anthony J.
    Heimanson, Zeev
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2017, 112 : S236 - S236
  • [2] EFFICACY OF RIFAXIMIN IN PATIENTS WITH DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND PRIOR USE OF IBS MEDICATIONS
    Lembo, Anthony J.
    Rao, Satish S.
    Rezaie, Ali
    Heimanson, Zeev
    Pimentel, Mark
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S499
  • [3] Rifaximin Repeat Treatment in Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D) Produced No Clinically Significant Changes in Stool Microbial Antibiotic Sensitivity
    Pimentel, Mark
    Chang, Lin
    Lembo, Anthony J.
    Wolf, Ray A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S761 - S761
  • [4] Improvements over Time in Individual Diarrhea-Predominant Irritable Bowel Syndrome Symptoms (IBS-D) with Rifaximin Repeat Treatment
    Pimentel, Mark
    Lembo, Anthony J.
    Wolf, Ray
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S240 - S240
  • [5] Infection-Related Safety Profile of Rifaximin Repeat Treatment for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Chey, William D.
    Lembo, Anthony J.
    Wolf, Ray A.
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2015, 110 : S750 - S751
  • [6] RIFAXIMIN REPEAT TREATMENT FOR DIARRHEA-PREDOMINANT IRRITABLE BOWEL SYNDROME (IBS-D) AND IMPACT ON CLOSTRIDIUM DIFFICILE INFECTION DEVELOPMENT
    Pimentel, Mark
    Schoenfeld, Phillip
    Heimanson, Zeev
    Cash, Brooks D.
    [J]. GASTROENTEROLOGY, 2018, 154 (06) : S499 - S500
  • [7] Analysis of Potential Predictors of Symptom Recurrence in Patients Treated with Rifaximin for Diarrhea-Predominant Irritable Bowel Syndrome (IBS-D)
    Lembo, Anthony J.
    Rao, Satish
    Wolf, Ray
    Pimentel, Mark
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S253 - S253
  • [8] The multiple effects of fecal microbiota transplantation on diarrhea-predominant irritable bowel syndrome (IBS-D) patients with anxiety and depression behaviors
    Hao Lin
    Qingqing Guo
    Zhiyong Wen
    Songlin Tan
    Jie Chen
    Lijian Lin
    Pengcheng Chen
    Jianquan He
    Jianbo Wen
    Ye Chen
    [J]. Microbial Cell Factories, 20
  • [9] Rifaximin in the Treatment of Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Dai, Cong
    Jiang, Min
    Sun, Ming-Jun
    [J]. GASTROENTEROLOGY, 2017, 152 (06) : 1629 - +
  • [10] Repeat Treatment With Rifaximin Is Safe and Effective in Patients With Diarrhea-Predominant Irritable Bowel Syndrome
    Lembo, Anthony
    Pimentel, Mark
    Rao, Satish S.
    Schoenfeld, Philip
    Cash, Brooks
    Weinstock, Leonard B.
    Paterson, Craig
    Bortey, Enoch
    Forbes, William P.
    [J]. GASTROENTEROLOGY, 2016, 151 (06) : 1113 - 1121